Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 3633 - 3640 of 12016 results
TCPA Regulatory Update — A Busy FCC Continues to Implement the TRACED Act; Public Notice on Flu Vaccines During the Pandemic
October 20, 2020| Article| Viewpoint
COVID-19 Telecommuting Tax and Leave Issues for Employers
October 20, 2020| Blog| Viewpoint
Bioethics in a Pandemic: Final Framework for Equitable Allocation of a COVID-19 Vaccine
October 20, 2020| Blog| Viewpoint
FDA Provides Update on Pre-Cert Program and Launches Digital Health Center of Excellence
October 19, 2020| Blog| Viewpoint
Myriad Section 230 Bills Show Agreement Still Out Of Reach
October 19, 2020| News
Family Gift Planning — Perhaps the Best Time Is Now
October 19, 2020| Advisory| Viewpoint
Has Big Law Finally Lost Its Follow-the-Pack Mentality?
October 19, 2020| News
Fate of PTAB Judges and Decisions Now in Hands of Supreme Court
October 15, 2020| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|